LianBio (LIANY)
OTCMKTS
· Delayed Price · Currency is USD
0.122
0.00 (0.00%)
At close: Apr 24, 2026
LianBio Market Cap
LianBio has a market cap or net worth of $13.20 million as of April 29, 2026. Its market cap has decreased by -59.16% in one year.
Market Cap
13.20M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.12
Market Cap Chart
Since November 1, 2021, LianBio's market cap has decreased from 1.44B to 13.20M, a decrease of -99.08%. That is a compound annual growth rate of -64.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 13.20M | 28.42% |
| Dec 31, 2025 | 10.28M | -64.15% |
| Dec 31, 2024 | 28.66M | -94.07% |
| Dec 29, 2023 | 483.04M | 171.83% |
| Dec 30, 2022 | 177.70M | -73.10% |
| Dec 31, 2021 | 660.59M | -54.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HOOKIPA Pharma | 14.15M |
| Zeo ScientifiX | 14.19M |
| Inhibitor Therapeutics | 15.53M |
| EOM Pharmaceuticals Holdings | 15.55M |
| Oncotelic Therapeutics | 15.90M |
| Finch Therapeutics Group | 10.39M |
| Anebulo Pharmaceuticals | 19.71M |
| Biomind Labs | 8.14M |